Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Current Medical Research and Opinion|April 13, 2012
Characterizing and understanding body weight patterns in patients treated with pregabalinJavier Cabrera, Birol Emir, Diana Dills, et al.The Clinical Journal of Pain|March 11, 2015
Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With FibromyalgiaCharles E Argoff, Andrew Clair, Birol Emir, et al.Pain Practice : the Official Journal of World Institute of Pain|November 28, 2013
A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic painRainer Freynhagen, Michael Serpell, Birol Emir, et al.Journal of Pain Research|June 20, 2015
Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical recordsBirol Emir, Elizabeth T Masters, Jack Mardekian, et al.Journal of Pain Research|March 19, 2015
Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilizationElizabeth T Masters, Jack Mardekian, Birol Emir, et al.Pain Practice : the Official Journal of World Institute of Pain|September 3, 2016
Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?Concepción Pérez, Mark Latymer, Mary Almas, et al.Trends in Pharmacological Sciences|May 7, 2013
The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?Stephen M Stahl, Frank Porreca, Charles P Taylor, et al.Pain Medicine (Malden, Mass.)|May 20, 2017
Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid DepressionStuart L Silverman, Miroslav Backonja, Lynne Pauer, et al.Postgraduate Medicine|August 13, 2013
Integrating health information technology and electronic health records into the management of fibromyalgiaAlvin F Wells, Lesley M Arnold, Cassandra E Curtis, et al.Pediatric Rheumatology Online Journal|August 1, 2016
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension studyLesley M Arnold, Kenneth N Schikler, Lucinda Bateman, et al.Pageof 3